Monday, May 18, 2026 | 08:54 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Astrazeneca Pharma India Ltd / Announcements / BSE

Astrazeneca Pharma India Ltd

Astrazeneca Pharma India Limited Has Received A Permission In Form CT-20 To Import For Sale And Distribution Of Trastuzumab Deruxtecan (Enhertu) 100Mg/5Ml Vial Lyophilized Powder For Concentrate For Solution For Infusion

06:45 PM, 3rd May 2023

Please find the enclosed letter of the Company in relation to the captioned subject for your reference.

More Astrazeneca Pharma India Ltd Announcements

    View more